glp-1 fatty liver disease GLP1 Therapy Gains Traction Treating Therapeutic Mechanisms and Clinical Effects

It is often grouped with semaglutide, but it works on two pathways rather than one, activating both the GIP and the GLP-1 receptors

The popularity of Wegovy, Mounjaro and Ozempic on social media platforms is spurring real-world effects

Furthermore, several of these therapies have only a modest glucose-lowering effect in people with reduced glomerular filtration [14]

Trends in first-time prescribing First-time prescribing rates (first-time GLP-1 RA prescriptions per total prescriptions) increased from 1.4% in December 2025 to 1.6% in March 2026 (+13.3%)

From initial consultation to ongoing support, Claya ensures that patients can maintain their progress without the disruptions caused by medication shortages